DiscoverIllumina Genomics PodcastClinical utility of ctDNA testing in lung cancer
Clinical utility of ctDNA testing in lung cancer

Clinical utility of ctDNA testing in lung cancer

Update: 2024-04-10
Share

Description

Atocha Romero, PharmD, PhD, explains the value of liquid biopsy-based comprehensive genomic profiling. Dr. Romero provides an overview of the results of the NADIM II clinical trials and discusses ctDNA testing to monitor disease and guide treatment. Atocha Romero, PharmD, PhD, is the director of the Liquid Biopsy Laboratory of the Medical Oncology Department at the Hospital Universitario Puerta de Hierro in Madrid, Spain.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Clinical utility of ctDNA testing in lung cancer

Clinical utility of ctDNA testing in lung cancer

Illumina Genomics Podcast